OPEN INNOVATION | Asahi Kasei Pharma Corporation


6th January, 2022 - 28th February, 2022


Registration must be completed by 22nd February, 2022

Application period: 5:00AM , Jan. 6, 2022 GMT to 8:00AM , Feb. 28, 2022 GMT

ASAHI KASEI PHARMA OPEN INNOVATION is an open innovation platform started in 2018 to recruit candidates for research collaborations related to drug discovery.

They aim to create innovative new drugs to match their corporate philosophy, ”contribute to life and living for people around the world”. Realizing this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.

They will accept a broad range of proposals from around the world based upon the programme criteria. They would like to have candidates that will work together with our researchers, who are professionals in drug discovery research, to promote drug discovery research with practical applications.

1. Autoimmune Diseases

2. Critical Care Medicine

3. Neurodegenerative Diseases

4. Pain and Neuropathy

5. Bone Diseases

6. Drug Discovery Platform Technology

Asahi Kasei Pharma Corporation will offer selected candidates collaborative research opportunities, with research funding and contribution to the program through their scientists’ research activities. If the program achieves progress, they will consider a separate license agreement that includes payments such as upfront, milestones, and royalties.